Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» 177Lu-PSMA-617
177Lu-PSMA-617
Oncologists on board for Novartis' prostate cancer radiotherapy, but logistics could hit uptake: survey
Fierce Pharma
Wed, 02/23/22 - 10:29 am
Novartis
prostate cancer
oncologists
radioligand
177Lu-PSMA-617
With clear regulatory path, Endocyte raises $175M
BioCentury
Tue, 09/11/18 - 11:29 pm
Endocyte
177Lu-PSMA-617
